Poland· PL-100284141
Veregen
A antivirals product containing cameliae sinensis folii extractum siccum, registered in Poland by ORNYX OÜ. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Cameliae sinensis folii extractum siccum is registered in 3 of 19 countries.
Countries holding a registration under ATC D06BB (antivirals), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Cameliae sinensis folii extractum siccum · ATC D06BB
3 / 19 countries
- Belgiumprice
- Finlandprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Cameliae sinensis folii extractum siccum
- Manufacturer
- ORNYX OÜ
- Country
- Poland (PL)
- ATC code
- D06BB
- ATC class
- Antivirals
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991001094
- gtin04745010711022
- gtin04745010711060
- gtin05909991001087
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cameliae sinensis folii extractum siccum in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVEREGENORNYX OÜ, Johvi vald
- United StatesThea sinensisBoiron
- SwitzerlandVeregen 10%, SalbeViatris Pharma GmbH
- GermanyVeregenAresus Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Veregen
- Cyprus · Veregreen
- Germany · Veregen
- Spain · Veregen
- United Kingdom (Northern Ireland) · Catephen
- Greece · Veregreen
- Ireland · Catephen
- Portugal · Veregen
- Romania · Veregen
- Slovenia · Veregen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/932d655b-d4a4-481a-b337-d724377be8ee GET /v1/drugs/932d655b-d4a4-481a-b337-d724377be8ee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "100 mg/g",
"packaging": "05909991001087 ¦ Rp ¦ Skasowane ¦ 78618\n1 tuba 15 g\n05909991001094 ¦ Rp ¦ Skasowane ¦ 78619\n1 tuba 30 g\n04745010711022 ¦ Rp ¦ 167551\n1 tuba 15 g\n04745010711060 ¦ Rp ¦ 167552\n1 tuba 30 g",
"substance": "cameliae sinensin folii extractum siccum 100 - 104 mg",
"common_name": "Cameliae sinensis folii extractum siccum",
"pl_product_id": "100284141",
"pozwolenie_nr": "20559",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about cameliae sinensis folii extractum siccum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.